Literature DB >> 25701907

Sleep in traumatic brain injury.

Nicole L Mazwi1, Heidi Fusco2, Ross Zafonte3.   

Abstract

Sleep disturbances affect more than half of survivors of traumatic brain injury (TBI) and have the potential to undermine rehabilitation, recovery, and outcomes. Normal sleep architecture has been well-described and the neurophysiology of sleep is becoming better understood in recent years, though this complex process continues to be dissected for better appreciation. There are numerous types of sleep disorder, most of which fall under two categories: dyssomnias and parasomnias. In more challenging scenarios patients may be plagued with more than one dyssomnia and/or parasomnia simultaneously, complicating the diagnostic and therapeutic approach. Objective and subjective methods are used to evaluate sleep disorders and help distinguish them from psychiatric and environmental contributors to poor sleep. There are several pharmacologic and nonpharmacologic treatments options for sleep disturbances after TBI, many of which have been particularly helpful in restoring adequate quantity and quality of sleep for survivors. However, to date no consensus has been established regarding how to treat this entity, and it may be that a multimodal approach is ultimately best.
© 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  circadian rhythm; insomnia; sleep disorder; traumatic brain injury

Mesh:

Year:  2015        PMID: 25701907     DOI: 10.1016/B978-0-444-63521-1.00035-2

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  2 in total

1.  Injury, Sleep, and Functional Outcome in Hospital Patients With Traumatic Brain Injury.

Authors:  Ellita T Williams; Diana Taibi Buchanan; Daniel J Buysse; Hilaire J Thompson
Journal:  J Neurosci Nurs       Date:  2019-06       Impact factor: 1.230

2.  Persistent CO2 reactivity deficits are associated with neurological dysfunction up to one year after repetitive mild closed head injury in adolescent mice.

Authors:  Limin Wu; Suk-Tak Chan; William J Edmiston; Gina Jin; Emily S Levy; Kenneth K Kwong; Rebekah Mannix; William P Meehan; Fortunate F Chifamba; Jonathan O Lipton; Michael J Whalen; Yin-Ching I Chen
Journal:  J Cereb Blood Flow Metab       Date:  2021-07-06       Impact factor: 6.960

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.